These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28419343)

  • 1. Utilizing a Modified Care Coordination Measurement Tool to Capture Value for a Pediatric Outpatient Parenteral and Prolonged Oral Antibiotic Therapy Program.
    Vaz LE; Farnstrom CL; Felder KK; Guzman-Cottrill J; Rosenberg H; Antonelli RC
    J Pediatric Infect Dis Soc; 2018 May; 7(2):136-142. PubMed ID: 28419343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Antimicrobial Stewardship for Pediatric Outpatient Parenteral Antibiotic Therapy.
    Hersh AL; Olson J; Stockmann C; Thorell EA; Knackstedt ED; Esquibel L; Sanderson S; Pavia AT
    J Pediatric Infect Dis Soc; 2018 May; 7(2):e34-e36. PubMed ID: 28549165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute dental infections managed in an outpatient parenteral antibiotic program setting: prospective analysis and public health implications.
    Connors WJ; Rabie HH; Figueiredo RL; Holton DL; Parkins MD
    BMC Infect Dis; 2017 Mar; 17(1):202. PubMed ID: 28279155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and outcomes of patients receiving outpatient parenteral antibiotic therapy in a Belgian setting: a single-center pilot study.
    Briquet C; Cornu O; Servais V; Blasson C; Vandeleene B; Yildiz H; Stainier A; Yombi JC
    Acta Clin Belg; 2020 Aug; 75(4):275-283. PubMed ID: 31023169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving outcomes through care coordination: Measuring care coordination of nurse practitioners.
    Ruggiero K; Pratt P; Antonelli R
    J Am Assoc Nurse Pract; 2019 Aug; 31(8):476-481. PubMed ID: 31389863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service.
    Durojaiye OC; Bell H; Andrews D; Ntziora F; Cartwright K
    Int J Antimicrob Agents; 2018 Jan; 51(1):26-32. PubMed ID: 28673610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mandatory infectious diseases approval of outpatient parenteral antimicrobial therapy (OPAT): clinical and economic outcomes of averted cases.
    Conant MM; Erdman SM; Osterholzer D
    J Antimicrob Chemother; 2014 Jun; 69(6):1695-700. PubMed ID: 24532684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of mandatory inpatient infectious disease consultation on outpatient parenteral antibiotic therapy.
    Sharma R; Loomis W; Brown RB
    Am J Med Sci; 2005 Aug; 330(2):60-4. PubMed ID: 16103785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by Hospital at Home units in Spain.
    González-Ramallo VJ; Mirón-Rubio M; Mujal A; Estrada O; Forné C; Aragón B; Rivera AJ
    Int J Antimicrob Agents; 2017 Jul; 50(1):114-118. PubMed ID: 28499957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A practical program for outpatient parenteral antimicrobial therapy].
    Ravelingien T; Buyle F; Deryckere S; Huis In 't Veld D; Debrauwere M; Verplancke K; Callens S; Commeyne S; Pattyn C; Somers A; Vogelaers D
    J Pharm Belg; 2016 Sep; (3):22-31. PubMed ID: 30281241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring of Outpatient Parenteral Antimicrobial Therapy and Implementation of Clinical Pharmacy Services at a Community Hospital Infusion Unit.
    Shah PJ; Bergman SJ; Graham DR; Glenn S
    J Pharm Pract; 2015 Oct; 28(5):462-8. PubMed ID: 25107418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective.
    Wai AO; Frighetto L; Marra CA; Chan E; Jewesson PJ
    Pharmacoeconomics; 2000 Nov; 18(5):451-7. PubMed ID: 11151398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient parenteral antimicrobial therapy (OPAT) versus inpatient care in the UK: a health economic assessment for six key diagnoses.
    Dimitrova M; Gilchrist M; Seaton RA
    BMJ Open; 2021 Sep; 11(9):e049733. PubMed ID: 34588251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic Burden of Home Antimicrobial Therapy: OPAT Versus Oral Therapy.
    Krah NM; Bardsley T; Nelson R; Esquibel L; Crosby M; Byington CL; Pavia AT; Hersh AL
    Hosp Pediatr; 2019 Apr; 9(4):234-240. PubMed ID: 30885919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient parenteral antibiotic therapy (OPAT) in Asia: missing an opportunity.
    Fisher D; Michaels J; Hase R; Zhang J; Kataria S; Sim B; Tsang JK; Pollard J; Chan M; Swaminathan S
    J Antimicrob Chemother; 2017 Apr; 72(4):1221-1226. PubMed ID: 28077673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introducing outpatient parenteral antimicrobial therapy in a children's hospital.
    Bolsover S
    Nurs Child Young People; 2018 Feb; 30(1):24-27. PubMed ID: 29412536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outpatient Parenteral Antimicrobial Therapy and Judicious Use of Pediatric Emergency Resources.
    Xu M; Doan Q
    Pediatr Emerg Care; 2020 May; 36(5):e247-e253. PubMed ID: 28697159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the implementation of a nurse-managed outpatient parenteral antibiotic therapy (OPAT) system in Baltimore: a case study demonstrating cost savings and reduction in re-admission rates.
    Mansour O; Heslin J; Townsend JL
    J Antimicrob Chemother; 2018 Nov; 73(11):3181-3188. PubMed ID: 30085088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective.
    Yong C; Fisher DA; Sklar GE; Li SC
    Int J Antimicrob Agents; 2009 Jan; 33(1):46-51. PubMed ID: 18823759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial stewardship in the outpatient parenteral antimicrobial therapy (OPAT) setting: the impact of prescription assessment by an infectious diseases specialist.
    Cassettari V; Novato N; Onuchic MHF
    Braz J Infect Dis; 2021; 25(2):101560. PubMed ID: 33716018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.